| Year |
Citation |
Score |
| 2023 |
Qian J, Yu X, Liu Z, Cai J, Manjili MH, Yang H, Guo C, Wang XY. SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine. Frontiers in Immunology. 14: 1118781. PMID 36793731 DOI: 10.3389/fimmu.2023.1118781 |
0.43 |
|
| 2020 |
Nie W, Xu MD, Gan L, Zhang Y, Qian J, Gu K, Zhang XY, Wang HM, Yan B, Gu P, Zhang B, Wang SY, Hu F, Li CH, Zhong H, et al. Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 32209830 DOI: 10.1097/CJI.0000000000000318 |
0.329 |
|
| 2017 |
Liu Y, Zhou S, Qian J, Wang Y, Yu X, Dai D, Dai M, Wu L, Liao Z, Xue Z, Wang J, Hou G, Ma J, Harley JB, Tang Y, et al. T-bet(+)CD11c(+) B cells are critical for antichromatin immunoglobulin G production in the development of lupus. Arthritis Research & Therapy. 19: 225. PMID 28982388 DOI: 10.1186/S13075-017-1438-2 |
0.301 |
|
| 2015 |
Zhang L, Bi E, Hong S, Qian J, Zheng C, Wang M, Yi Q. CD4+ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma. Oncotarget. PMID 26447613 DOI: 10.18632/oncotarget.5506 |
0.541 |
|
| 2015 |
Lin XB, Jiang L, Ding MH, Chen ZH, Bao Y, Chen Y, Sun W, Zhang CR, Hu HK, Cai Z, Lu CY, Zhou JY, Qian J, Wu XJ, Jin WL, et al. Anti-tumor activity of phenoxybenzamine hydrochloride on malignant glioma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26409450 DOI: 10.1007/s13277-015-4102-y |
0.32 |
|
| 2013 |
Cobbold M, De La Peña H, Norris A, Polefrone JM, Qian J, English AM, Cummings KL, Penny S, Turner JE, Cottine J, Abelin JG, Malaker SA, Zarling AL, Huang HW, Goodyear O, et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Science Translational Medicine. 5: 203ra125. PMID 24048523 DOI: 10.1126/Scitranslmed.3006061 |
0.365 |
|
| 2013 |
Yu X, Guo C, Yi H, Qian J, Fisher PB, Subjeck JR, Wang XY. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity. Cancer Research. 73: 2093-103. PMID 23333935 DOI: 10.1158/0008-5472.Can-12-1740 |
0.507 |
|
| 2012 |
Guo C, Yi H, Yu X, Zuo D, Qian J, Yang G, Foster BA, Subjeck JR, Sun X, Mikkelsen RB, Fisher PB, Wang XY. In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer. Molecular Cancer Therapeutics. 11: 2331-41. PMID 22896667 DOI: 10.1158/1535-7163.Mct-12-0164 |
0.446 |
|
| 2011 |
Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, Manjili MH, Fisher PB, Subjeck JR, Wang XY. Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Research. 71: 6611-20. PMID 21914786 DOI: 10.1158/0008-5472.Can-11-1801 |
0.46 |
|
| 2011 |
Qian J, Yi H, Guo C, Yu X, Zuo D, Chen X, Kane JM, Repasky EA, Subjeck JR, Wang XY. CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. Journal of Immunology (Baltimore, Md. : 1950). 187: 2905-14. PMID 21832164 DOI: 10.4049/Jimmunol.1100703 |
0.408 |
|
| 2010 |
Brims DR, Qian J, Jarchum I, Mikesh L, Palmieri E, Ramagopal UA, Malashkevich VN, Chaparro RJ, Lund T, Hattori M, Shabanowitz J, Hunt DF, Nathenson SG, Almo SC, Dilorenzo TP. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. International Immunology. 22: 191-203. PMID 20093428 DOI: 10.1093/Intimm/Dxp127 |
0.63 |
|
| 2009 |
Depontieu FR, Qian J, Zarling AL, McMiller TL, Salay TM, Norris A, English AM, Shabanowitz J, Engelhard VH, Hunt DF, Topalian SL. Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proceedings of the National Academy of Sciences of the United States of America. 106: 12073-8. PMID 19581576 DOI: 10.1073/Pnas.0903852106 |
0.806 |
|
| 2007 |
Cobbold M, Polefrone JM, Qian J, Mohammed F, Norris A, De Santis AM, Zarling AL, Shabanowitz J, Willcox BE, Williams ME, Hunt DF, Engelhard VH. Immune Targeting of the Phosphoproteome in Lymphoma and Leukemia. Blood. 110: 285-285. DOI: 10.1182/Blood.V110.11.285.285 |
0.746 |
|
| Show low-probability matches. |